GPT and COVID-19: Among patients admitted due to COVID-19 (n = 72), raised aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were shown in 63 and 39% of cases (Fig. 1b), respectively despite the low frequency of liver disease (1.4%), confirming previous studies4–11.